Advertisement
Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Andrew Rowland, Paraskevi Gaganis, David J. Elliot, Peter I. Mackenzie, Kathleen M. Knights and John O. Miners
Journal of Pharmacology and Experimental Therapeutics April 2007, 321 (1) 137-147; DOI: https://doi.org/10.1124/jpet.106.118216
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMETABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Andrew Rowland, Paraskevi Gaganis, David J. Elliot, Peter I. Mackenzie, Kathleen M. Knights and John O. Miners
Journal of Pharmacology and Experimental Therapeutics April 1, 2007, 321 (1) 137-147; DOI: https://doi.org/10.1124/jpet.106.118216
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement